This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Hidden Cost of Innovation: Unpacking the Expenses Behind Pharmaceutical Patents As a healthcare professional or industry insider, you're likely no stranger to the complex world of pharmaceutical patents. But have you ever stopped to think about the actual cost of securing one of these coveted protections? In this post, we'll delve into the often-overlooked expenses associated with pharmaceutical patents, and explore what it takes to bring a new medication to market.
A recent Nature Medicine research report is sounding an alarm. The risk of developing dementia by the age of 95 is 42%. The finding that the risk of dementia increases with age is well described. What’s new and startling about this result is the number. It’s double prior estimates. The investigator team, led by researchers at New York University and funded by the National Institutes of Health, reported even higher risk estimates for women, people who self-report Black racial identi
The community pharmacy contractual framework in each UK nation must minimise the risk of individual contractors incurring a potential loss on the purchase of medicines, the Royal Pharmaceutical Society (RPS) has said. In response to the All-Party Parliamentary Group (APPG) on Pharmacy's call for written evidence on medicines shortages, the RPS warned pharmacy funding must […] The post Pharmacy contract must minimise risk of dispensing at a loss, MPs told appeared first on The Pharmacist.
The much-awaited extension for the implementation of guidelines under Schedule M is finally here. In a notification issued earlier this month, The Union Health Ministry has granted a one-year extension to small and medium-sized pharmaceutical companies to upgrade their facilities as per the revised Schedule M of the Drugs and Cosmetic Act. However, this breather comes with a condition–SMEs will have to register with the Central Drug Standards Control Organization (CDSCO) and submit their u
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Merck’s Keytruda has been used against dozens of different cancers in millions of patients, making it the top-selling drug in the world, with over $25 billion in revenue in 2023.
Several batches of Tesco, Asda, Almus and Bells cough syrup have been recalled after a customer complained of finding 'foreign material' in a bottle. After identifying that some bottles were contaminated, manufacturer Bells Healthcare has recalled several batches of the dextromethorphan hydrobromide BP containing products 'as a precautionary measure'.
113
113
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Several batches of Tesco, Asda, Almus and Bells cough syrup have been recalled after a customer complained of finding 'foreign material' in a bottle. After identifying that some bottles were contaminated, manufacturer Bells Healthcare has recalled several batches of the dextromethorphan hydrobromide BP containing products 'as a precautionary measure'.
Kenvue has expanded its Ready-to-Drink (RTD) rehydration portfolio with the launch of ORS, a WHO-approved formula designed for patients experiencing diarrhoea-induced dehydration. With this addition, Kenvue now offers a comprehensive hydration portfolio addressing both diarrheal and non-diarrheal dehydration. A Kenvue study, Wide Variability in Osmolarity of Reconstituted Powdered Oral Rehydration Salts Due to Disparity in the Method of Preparation Among Indian Consumers published in Journal of
For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. You can find our updated counting below. As youll see below, the combination of formulary exclusion and private labels is creating an increasingly confusing and crowded biosimilar marketplace.
Pfizer agreed to pay nearly $60 million to resolve allegations that its Biohaven Pharmaceuticals unit paid kickbacks to entice physicians to prescribe a migraine treatment. The alleged violations occurred before Pfizer bought the company three years ago, according to the U.S. Department of Justice. The authorities alleged that, from March 2020 through September 2022, Biohaven improperly paid doctors speaking fees and for meals at “high end” restaurants in order to persuade them to
The pharmacy common ailments service in Wales saw 420,951 patients in the last 12 months, new figures from the Welsh Government have revealed. This brings the total number of people who have accessed the service since it launched in 2013 to almost 1.25m. The figures were shared in advance of a speech made in the […] The post Welsh common ailments service saw more than 400,000 patients last year appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive and Health Technologies and President, Association of Herbal and Nutraceutical Manufacturers of India “As we dream of Viksit Bharat in 2047, it cannot happen without Swasth Bharat. Health is a very significant area of development in India. Despite the progress achieved so far, health expenditure has been a mere 3.37 per cent of GDP trailing the targeted 5 per cent of GDP for universal coverage of health services.
Breaking Down Barriers to Affordable Healthcare: The Power of Biosimilars As we navigate the complex landscape of modern healthcare, one thing is clear: the cost of prescription medications is a significant burden for many patients. The rising cost of brand-name medications has left millions of people struggling to afford the treatments they need to manage their conditions.
Eleos Health, maker of a product that generates clinical notes from audio of behavioral health appointments, has raised $60 million on the bet that therapy is different enough from other health care that providers need entirely different software. The rise of large language models that can efficiently summarize text has fueled the rapid development of companies using the technology to take documentation burden off overworked clinicians.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Opella, Sanofis Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis (tadalafil) from a prescription to an over-the-counter medicine. This decision allows for the initiation of the AUT and makes Cialis the first PDE-5 inhibitor to achieve this milestone.
The Unseen Heroes of Generic Drug Manufacturing: Good Manufacturing Practice (GMP) As we navigate the complex world of generic drug manufacturing, it's easy to overlook the unsung heroes that ensure the quality and safety of these life-saving medications. I'm talking about Good Manufacturing Practice (GMP), a set of guidelines that govern the production, testing, and packaging of generic drugs.
Plant-based foods are center stage in the new scientific report from the Dietary Guidelines Advisory Committee (DGAC). The committee recommended that the 2025-2030 Dietary Guidelines “include more nutrient-dense plant-based meal and dietary recommendation options,” prioritize plant-based protein over animal protein, and center plain water, instead of dairy milk and soda, as a beverage of choice.
The US Food and Drug Administration (FDA) has approved the first monotherapy for adults with treatment-resistant depression.Johnson & Johnsons SPRAVATO (esketamine) CIII nasal spray is indicated for major depressive disorder (MDD). Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Bhubaneswar based biotech startup Exsure has raised rupees three crores in a seed round led by Unicorn India Ventures. The funds raised will be used to complete the milestones of non-clinical study with its exosome-based drug delivery vehicle and will also support Exsures global expansion plan with its in-house manufactured R&D products and promote Exosure, Leucosure, PlantExosure and Dr Berries.
The Science Behind Generic Drug Bioequivalence: Separating Fact from Fiction As a healthcare professional or someone simply looking to stay informed, you've likely heard the term "bioequivalence" thrown around when it comes to generic drugs. But what does it really mean, and how does it impact the medications we take? Bioequivalence is a crucial concept in the world of pharmaceuticals, ensuring that generic versions of brand-name medications are just as effective as their original coun
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! It’s cold outside and dry dry dry inside the office here at STAT headquarters. It’s so bad, I almost considered smearing beef tallow all over my face. (While drafting this newsletter, one editor already reached out asking me not to do this.
A new and exclusive series set to be released over the coming weeks will explore how the ARRS has altered the pharmacy landscape both in practices and community settings while shining a light on the workforce issues facing both sectors In the past, GP practices mostly comprised doctors, nurses and administrative staff. But […] The post New series: Has the ARRS been a positive or a negative?
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Strides Pharma Science announces that the company has received an ESG score of 76/100 and a CSA score of 75/100 in the Corporate Sustainability Assessment (CSA) Annual Review (vide report dated January 20, 2025) for its debut submission. Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry.
Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the belief the answer could come down to delivery.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I’m still recovering from yesterday, when Chicago was reportedly colder than Antarctica. I hope you’re all staying warm wherever you are. Let’s get into the news today.
In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and Alnylam in a closely watched commercial battle.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Glenmark Pharmaceuticals USA announces the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules. Glenmarks Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, ANDA 087955. According to IQVIA sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales
The federal government is officially backing down from a courtroom fight with the country’s largest Medicare Advantage insurer, just three days after it said it was ready to spar.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
53 
Let's personalize your content